EI
EAM Investors Portfolio holdings
AUM
$660M
This Quarter Return
+45.29%
1 Year Return
+271.72%
3 Year Return
+5,059.16%
5 Year Return
+72,876.1%
10 Year Return
+9,525,948.1%
AUM
$483M
AUM Growth
+$483M
(+5%)
Cap. Flow
-$35.5M
Cap. Flow
% of AUM
-7.35%
Top 10 Holdings %
Top 10 Hldgs %
9.87%
Holding
378
New
132
Increased
14
Reduced
97
Closed
129
Top Buys
| 1 |
Viking Therapeutics
VKTX
|
$4.65M |
| 2 |
PDS Biotechnology
PDSB
|
$4.36M |
| 3 |
KLX Energy Services
KLXE
|
$4.07M |
| 4 |
Par Pacific Holdings
PARR
|
$3.31M |
| 5 |
Tidewater
TDW
|
$3.28M |
Top Sells
| 1 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$5.93M |
| 2 |
Cogent Biosciences
COGT
|
$5.04M |
| 3 |
Lantheus
LNTH
|
$4.84M |
| 4 |
Sensus Healthcare
SRTS
|
$4.1M |
| 5 |
Cytokinetics
CYTK
|
$3.74M |
Sector Composition
| 1 | Healthcare | 30.56% |
| 2 | Industrials | 17.86% |
| 3 | Technology | 16.26% |
| 4 | Energy | 11.75% |
| 5 | Financials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
ADMA Biologics
ADMA
$4.12B
| $6.79M | 1.41% | 1,749,598 +322,438 | +23% | +$1.25M |
|
2
UFP Technologies
UFPT
$1.62B
| $5.86M | 1.21% | 49,672 +7,260 | +17% | +$856K |
|
3
Rhythm Pharmaceuticals
RYTM
$6.85B
| $4.8M | 0.99% | 164,695 -34,004 | -17% | -$990K |
|
|
4
Viking Therapeutics
VKTX
$3.04B
| $4.65M | 0.96% | +494,940 | New | +$4.65M |
|
5
Target Hospitality
TH
$905M
| $4.6M | 0.95% | 304,011 -106,103 | -26% | -$1.61M |
|
|
6
PDS Biotechnology
PDSB
$57.8M
| $4.36M | 0.9% | +330,426 | New | +$4.36M |
|
7
Digi International
DGII
$1.29B
| $4.3M | 0.89% | 117,746 -641 | -0.5% | -$23.4K |
|
8
Ceco Environmental
CECO
$1.61B
| $4.25M | 0.88% | 363,995 -524 | -0.1% | -$6.12K |
|
|
9
KLX Energy Services
KLXE
$35M
| $4.07M | 0.84% | +234,913 | New | +$4.07M |
|
10
Arcellx
ACLX
$3.85B
| $3.98M | 0.82% | 128,525 -761 | -0.6% | -$23.6K |
|
11
Agilysys
AGYS
$3.06B
| $3.96M | 0.82% | 50,028 -197 | -0.4% | -$15.6K |
|
12
MGP Ingredients
MGPI
$630M
| $3.94M | 0.81% | 36,995 -6,163 | -14% | -$656K |
|
13
Impinj
PI
$5.45B
| $3.89M | 0.81% | 35,661 -6,446 | -15% | -$704K |
|
14
Destination XL Group
DXLG
$69.4M
| $3.66M | 0.76% | 542,285 -629 | -0.1% | -$4.25K |
|
15
Transmedics
TMDX
$3.92B
| $3.58M | 0.74% | 57,944 -19,367 | -25% | -$1.2M |
|
16
89bio
ETNB
$1.34B
| $3.51M | 0.73% | 275,943 +85,225 | +45% | +$1.08M |
|
17
Hudson Technologies
HDSN
$444M
| $3.51M | 0.73% | 346,347 -18,990 | -5% | -$192K |
|
|
CBAY
18
DELISTED
Cymabay Therapeutics
CBAY
| $3.45M | 0.71% | 550,470 +210,692 | +62% | +$1.32M |
|
19
Harrow
HROW
$1.44B
| $3.44M | 0.71% | 232,908 +8,862 | +4% | +$131K |
|
|
BELFB
20
Bel Fuse Class B
BELFB
$1.7B
| $3.43M | 0.71% | 104,333 -40,648 | -28% | -$1.34M |
|
21
Richardson Electronics
RELL
$142M
| $3.41M | 0.71% | 159,655 -7,946 | -5% | -$169K |
|
22
e.l.f. Beauty
ELF
$7.09B
| $3.37M | 0.7% | 60,937 -21,851 | -26% | -$1.21M |
|
23
Huron Consulting
HURN
$2.37B
| $3.36M | 0.7% | 46,324 -254 | -0.5% | -$18.4K |
|
|
RXDX
24
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $3.36M | 0.69% | 30,504 -19,550 | -39% | -$2.15M |
|
25
Aehr Test Systems
AEHR
$746M
| $3.32M | 0.69% | 165,102 -144,538 | -47% | -$2.91M |
|